Infusion therapy technology is defined as a drug delivery technique in
which medication is provided via needle or catheter. Infusion therapy is
used, when medication cannot be provided to patient orally. Needles,
Infusion pumps, I.V. sets, and docking stations are the most common
infusion therapy devices used in medical applications. Infusion therapy
devices are widely used in chemotherapy, diabetes, homecare etc. the
global infusion therapy devices market is anticipated to grow with the
CAGR of 6.2% during the period 2017-2022. Increasing application of
infusion devices for reliving pain, increasing demand of ambulatory
infusion pumps and increasing prevalence of the chronic diseases across
the globe are estimated to augment the growth of the market. Moreover,
increasing geriatric population and growing number of surgical procedure
performed across the globe are also estimated to be one of the major
factors that are driving the growth of the market.
However, reimbursement issues in the medical devices industry, along
with it uncertain regulatory framework in the medical devices sectors
are estimated to be the major constraints in the growth of the market.
Besides these restraints, increasing adoption of the specialty infusion
systems and improving healthcare infrastructure in the developing
countries such as India, Brazil, and China are developing numerous
expansion opportunities for the growth of the market.
The global infusion therapy devices market is analyzed on the basis of the products, applications and end-users. On the basis of the products, our market is segmented into infusion pumps, intravenous set, needleless connectors, consumables, accessories and arterial devices. Infusion pumps are estimated to account for major share in the global infusion therapy devices market owing to high demand of ambulatory infusion pumps and increasing demand of infusion pumps in developing economies. Furthermore, on the basis of the applications, our market is bifurcated into oncology/chemotherapy, diabetes, gastroenterology, analgesia/pain management, pediatrics/ neonatology, hematology and others. And on the basis of the end-users, market is segmented into hospitals, homecare, ambulatory surgery centers and others. Hospitals are estimated to be the leading end-users of the infusion therapy devices, whereas ambulatory surgery centers are the fastest growing segment during the forecast period.
Geography insights
The global infusion therapy devices is further bifurcated on the basis of the geographical regions that are contributing significantly towards the growth of the market. On the basis of the geography, our market is further bifurcated into North America, Asia Pacific, Europe and Rest of the World. North America is estimated to account for major share in the global infusion therapy devices market owing to increasing prevalence of the chronic diseases in the region and well established healthcare infrastructure in the region. Asia Pacific is estimated to be the fastest growing region in the market during the forecast period. Large population coupled with increasing geriatric population and increasing prevalence of the chronic diseases are estimated to augment the growth of the market in the region. Moreover, expansion of private hospitals to rural areas, rising awareness and accessibility of advanced healthcare facilities are also estimated to drive the growth of the market in the region.
Competitive insights
Key players of the global infusion therapy market are B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Caesarea Medical Electronics, Carefusion Corporation, Fresenius Kabi AG, ICU Medical Inc., Jhonson & Jhonson, JMS Co. Ltd., Kimberly-Clark Corporation, Medtronic Ltd., Moog Inc., Novartis, Pfizer Inc., Roche Diagnostics Corporation, Smiths Medical, Terumo Corporation and so on. Key strategies used by these players to sustain in the market are mergers, acquisitions, product launch and geographical expansion.
OMR Report covers
• Comprehensive research methodology of global infusion therapy devices market.
• This report also includes detailed and extensive market overview with Analyst insights & key market trends.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global infusion therapy devices market.
• Insights about market determinants which are stimulating the global infusion therapy devices market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING APPLICATION OF INFUSION DEVICES FOR RELIVING PAIN
3.1.2. INCREASING PREVALENCE OF CHRONIC DISEASES
3.1.3. RISING DEMAND OF AMBULATORY INFUSION PUMP
3.1.4. SURGING GERIATRIC POPULATION
3.1.5. GROWING NUMBER OF SURGICAL PROCEDURES PERFORMED
3.2. RESTRAINTS
3.2.1. REIMBURSEMENT CHALLENGES IN THE MEDICAL DEVICES INDUSTRY
3.2.2. UNCERTAIN REGULATORY FRAMEWORK FOR MEDICAL DEVICES INDUSTRY
3.3. OPPORTUNITIES
3.3.1. INCREASING ADOPTION OF SPECIALTY INFUSION SYSTEMS
3.3.2. IMPROVING HEALTHCARE INFRASTRUCTURE IN DEVELOPING ECONOMIES
4. MARKET SEGMENTATION
4.1. GLOBAL INFUSION THERAPY DEVICE MARKET BY PRODUCT
4.1.1. INFUSION PUMPS
4.1.2. INTRAVENOUS SET
4.1.3. NEEDLELESS CONNECTORS
4.1.4. CONSUMABLES
4.1.5. ACCESSORIES
4.1.6. ARTERIAL DEVICES
4.2. GLOBAL INFUSION THERAPY DEVICE MARKET BY END-USERS
4.2.1. HOSPITALS
4.2.2. HOMECARE
4.2.3. AMBULATORY SURGERY CENTRES
4.2.4. OTHERS
4.3. GLOBAL INFUSION THERAPY DEVICE MARKET BY APPLICATIONS
4.3.1. ONCOLOGY/CHEMOTHERAPY
4.3.2. DIABETES
4.3.3. GASTROENTEROLOGY
4.3.4. ANALGESIA/PAIN MANAGEMENT
4.3.5. PEDIATRICS/NEONATOLOGY
4.3.6. HEMATOLOGY
4.3.7. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGY ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. B. BRAUN MELSUNGEN AG
7.1.1. INTRODUCTION
7.1.2. B. BRAUN MELSUNGEN AG PRODUCT PORTFOLIO
7.1.3. B. BRAUN MELSUNGEN AG RECENT ACTIVITIES
7.2. BAXTER INETRNATIONAL INC.
7.2.1. INTRODUCTION
7.2.2. BAXTER INETRNATIONAL INC. PRODUCT PORTFOLIO
7.2.3. BAXTER INETRNATIONAL INC. RECENT ACTIVITIES
7.3. BECTON, DICKINSON AND COMPANY
7.3.1. INTRODUCTION
7.3.2. BECTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
7.3.3. BECTON, DICKINSON AND COMPANY RECENT ACTIVITIES
7.4. CAESAREA MEDICAL ELECTRONICS
7.4.1. INTRODUCTION
7.4.2. CAESAREA MEDICAL ELECTRONICS PRODUCT PORTFOLIO
7.4.3. CAESAREA MEDICAL ELECTRONICS RECENT ACTIVITIES
7.5. CAREFUSION CORPORATION
7.5.1. INTRODUCTION
7.5.2. CAREFUSION CORPORATION PRODUCT PORTFOLIO
7.5.3. CAREFUSION CORPORATION RECENT ACTIVITIES
7.6. FRESENIUS KABI AG
7.6.1. INTRODUCTION
7.6.2. FRESENIUS KABI AG PRODUCT PORTFOLIO
7.6.3. FRESENIUS KABI AG RECENT ACTIVITIES
7.7. ICU MEDICAL INC.
7.7.1. INTRODUCTION
7.7.2. ICU MEDICAL INC. PRODUCT PORTFOLIO
7.7.3. ICU MEDICAL INC. RECENT ACTIVITIES
7.8. JHONSON AND JHONSON
7.8.1. INTRODUCTION
7.8.2. JHONSON AND JHONSON PRODUCT PORTFOLIO
7.8.3. JHONSON AND JHONSON RECENT ACTIVITIES
7.9. JMS CO. LTD.
7.9.1. INTRODUCTION
7.9.2. JMS CO. LTD. PRODUCT PORTFOLIO
7.9.3. JMS CO. LTD. RECENT ACTIVITIES
7.10. KIMBERLY-CLARK CORPORATION
7.10.1. INTRODUCTION
7.10.2. KIMBERLY-CLARK CORPORATION PRODUCT PORTFOLIO
7.10.3. KIMBERLY-CLARK CORPORATION RECENT ACTIVITIES
7.11. MEDTRONICS LTD.
7.11.1. INTRODUCTION
7.11.2. MEDTRONICS LTD. PRODUCT PORTFOLIO
7.11.3. MEDTRONICS LTD. RECENT ACTIVITIES
7.12. MOOG INC.
7.12.1. INTRODUCTION
7.12.2. MOOG INC. PRODUCT PORTFOLIO
7.12.3. MOOG INC. AB RECENT ACTIVITIES
7.13. NOVARTIS
7.13.1. INTRODUCTION
7.13.2. NOVARTIS PRODUCT PORTFOLIO
7.13.3. NOVARTIS RECENT ACTIVITIES
7.14. PFIZER INC.
7.14.1. INTRODUCTION
7.14.2. PFIZER INC. PRODUCT PORTFOLIO
7.14.3. PFIZER INC. RECENT ACTIVITIES
7.15. ROCHE DIAGONSTICS CORPORATION
7.15.1. INTRODUCTION
7.15.2. ROCHE DIAGONSTICS CORPORATION PRODUCT PORTFOLIO
7.15.3. ROCHE DIAGONSTICS CORPORATION RECENT ACTIVITIES
7.16. SMITHS MEDICAL
7.16.1. INTRODUCTION
7.16.2. SMITHS MEDICAL PRODUCT PORTFOLIO
7.16.3. SMITHS MEDICAL RECENT ACTIVITIES
7.17. TERUMO CORPORATION
7.17.1. INTRODUCTION
7.17.2. TERUMO CORPORATION PRODUCT PORTFOLIO
7.17.3. TERUMO CORPORATION RECENT ACTIVITIES
TABLE # 1 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY PRODUCTS 2015-2022 ($ MILLION)
TABLE # 2 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY INFUSION PUMPS 2015-2022 ($ MILLION)
TABLE # 3 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY INTRAVENOUS SET 2015-2022 ($ MILLION)
TABLE # 4 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY NEEDLELESS CONNECTOR 2015-2022 ($ MILLION)
TABLE # 5 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY CONSUMABLES 2015-2022 ($ MILLION)
TABLE # 6 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY ACCESSORIES 2015-2022 ($ MILLION)
TABLE # 7 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY ARTERIAL DEVICES 2015-2022 ($ MILLION)
TABLE # 8 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY APPLICATIONS 2015-2022 ($ MILLION)
TABLE # 9 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY ONCOLOGY/CHEMOTHERAPY 2015-2022 ($ MILLION)
TABLE # 10 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY DIABETES 2015-2022 ($ MILLION)
TABLE # 11 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY GASTROENTEROLOGY 2015-2022 ($ MILLION)
TABLE # 12 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY ANALGESIA/PAIN MANAGEMENT 2015-2022 ($ MILLION)
TABLE # 13 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY PEDIATRICS/ NEONATOLOGY 2015-2022 ($ MILLION)
TABLE # 14 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY HEMATOLOGY 2015-2022 ($ MILLION)
TABLE # 15 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY OTHERS 2015-2022 ($ MILLION)
TABLE # 16 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY END-USERS 2015-2022 ($ MILLION)
TABLE # 17 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY HOSPITALS 2015-2022 ($ MILLION)
TABLE # 18 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY HOMECARE 2015-2022 ($ MILLION)
TABLE # 19 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY AMBULATORY SURGERY CENTRES 2015-2022 ($ MILLION)
TABLE # 20 GLOBAL INFUSION THERAPY DEVICE MARKET RESEARCH AND ANALYSIS, BY OTHERS 2015-2022 ($ MILLION)
TABLE # 21 B. BRAUN MELSUNGEN AG PRODUCT PORTFOLIO
TABLE # 22 B. BRAUN MELSUNGEN AG RECENT ACTIVITIES
TABLE # 23 BAXTER INETRNATIONAL INC. PRODUCT PORTFOLIO
TABLE # 24 BAXTER INETRNATIONAL INC. RECENT ACTIVITIES
TABLE # 25 BECTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
TABLE # 26 BECTON, DICKINSON AND COMPANY RECENT ACTIVITIES
TABLE # 27 CAESAREA MEDICAL ELECTRONICS PRODUCT PORTFOLIO
TABLE # 28 CAESAREA MEDICAL ELECTRONICS RECENT ACTIVITIES
TABLE # 29 CAREFUSION CORPORATION PRODUCT PORTFOLIO
TABLE # 30 CAREFUSION CORPORATION RECENT ACTIVITIES
TABLE # 31 FRESENIUS KABI AG PRODUCT PORTFOLIO
TABLE # 32 FRESENIUS KABI AG RECENT ACTIVITIES
TABLE # 33 ICU MEDICAL INC. PRODUCT PORTFOLIO
TABLE # 34 ICU MEDICAL INC. RECENT ACTIVITIES
TABLE # 35 JHONSON AND JHONSON PRODUCT PORTFOLIO
TABLE # 36 JHONSON AND JHONSON RECENT ACTIVITIES
TABLE # 37 JMS CO. LTD. PRODUCT PORTFOLIO
TABLE # 38 JMS CO. LTD. RECENT ACTIVITIES
TABLE # 39 KIMBERLY-CLARK CORPORATION PRODUCT PORTFOLIO
TABLE # 40 KIMBERLY-CLARK CORPORATION RECENT ACTIVITIES
TABLE # 41 MEDTRONICS LTD. PRODUCT PORTFOLIO
TABLE # 42 MEDTRONICS LTD. RECENT ACTIVITIES
TABLE # 43 MOOG INC. PRODUCT PORTFOLIO
TABLE # 44 MOOG INC. AB RECENT ACTIVITIES
TABLE # 45 NOVARTIS PRODUCT PORTFOLIO
TABLE # 46 NOVARTIS RECENT ACTIVITIES
TABLE # 47 PFIZER INC. PRODUCT PORTFOLIO
TABLE # 48 PFIZER INC. RECENT ACTIVITIES
TABLE # 49 ROCHE DIAGONSTICS CORPORATION PRODUCT PORTFOLIO
TABLE # 50 ROCHE DIAGONSTICS CORPORATION RECENT ACTIVITIES
TABLE # 51 SMITHS MEDICAL PRODUCT PORTFOLIO
TABLE # 52 SMITHS MEDICAL RECENT ACTIVITIES
TABLE # 53 TERUMO CORPORATION PRODUCT PORTFOLIO
TABLE # 54 TERUMO CORPORATION RECENT ACTIVITIES
FIGURE # 1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 2 US MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 6 FRANCE MARKET RESE
FIGURE # 7 ARCH AND ANALYSIS, 2015-2022
FIGURE # 8 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 9 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 10 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 11 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 12 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 13 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 14 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 15 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 16 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 17 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022